A Pillared Approach: A Suite of Therapies for a Spectrum of Metabolic Disease

A look into how SGLT2 inhibitors, GLP-1 RAs, and nsMRAs have redefined the management of cardio-kidney-metabolic diseases.

For nearly a decade now, an evolution in the management of metabolic conditions has been happening in plain sight.